‘Invest bravely’: Cancer-fighting giant sets sights on Australia - Sydney Morning Herald

Australia’s streamlined trials approval system and its diverse patient population attracted the Beijing-founded pharmaceuticals firm.

Australias speedy clinical trials system has led another multibillion-dollar biotech to set up on its shores, with Nasdaq-listed cancer-fighter BeiGene enrolling thousands of patients in local clinic… [+1852 chars]

full article...